Discontinued — last reported Q4 '25
D&A
Cardinal Health D&A increased by 6.0% to $248.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 19.8%, from $207.00M to $248.00M. Over 4 years (FY 2021 to FY 2025), D&A shows relatively stable performance with a 0.2% CAGR.
Analysis
How to read this metric
Higher levels typically reflect significant historical capital expenditures or acquisitions that are now being expensed over time.
Detailed definition
This metric represents the non-cash accounting charges used to allocate the cost of tangible assets and intangible asset...
Peer comparison
Capital-intensive hardware manufacturers generally show higher D&A relative to revenue than pure-play software companies.
depreciation_and_amortization_cfHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $180.00M | $168.00M | $164.00M | $181.00M | $179.00M | $171.00M | $170.00M | $175.00M | $176.00M | $172.00M | $175.00M | $177.00M | $186.00M | $182.00M | $192.00M | $207.00M | $209.00M | $233.00M | $234.00M | $248.00M |
| QoQ Change | — | -6.7% | -2.4% | +10.4% | -1.1% | -4.5% | -0.6% | +2.9% | +0.6% | -2.3% | +1.7% | +1.1% | +5.1% | -2.2% | +5.5% | +7.8% | +1.0% | +11.5% | +0.4% | +6.0% |
| YoY Change | — | — | — | — | -0.6% | +1.8% | +3.7% | -3.3% | -1.7% | +0.6% | +2.9% | +1.1% | +5.7% | +5.8% | +9.7% | +16.9% | +12.4% | +28.0% | +21.9% | +19.8% |
Business Segments
| Segment | Q4 '22 | Q1 '23 | Q2 '23 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Pharmaceutical and Specialty Solutions | — | — | — | $44.00M | $68.00M | $61.00M | $64.00M | $70.00M |
| Cost of product sold | — | — | — | $56.00M | $47.00M | $55.00M | $55.00M | $54.00M |
| Other Segments | — | — | — | $31.00M | $0.00 | $29.00M | $30.00M | $26.00M |
| Medical | $53.25M | $53.25M | $53.25M | — | — | — | — | — |
| Pharmaceutical | $56.25M | $56.25M | $56.25M | — | — | — | — | — |
| Total | $170.00M | $175.00M | $176.00M | $207.00M | $209.00M | $233.00M | $234.00M | $248.00M |
Medical, Pharmaceutical are derived from annual filings.
Medical, Pharmaceutical were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.
D&A at Other Companies
Frequently Asked Questions
- What is Cardinal Health's d&a?
- Cardinal Health (CAH) reported d&a of $248.00M in Q1 2026.
- How has Cardinal Health's d&a changed year-over-year?
- Cardinal Health's d&a increased by 19.8% year-over-year, from $207.00M to $248.00M.
- What is the long-term trend for Cardinal Health's d&a?
- Over 4 years (2021 to 2025), Cardinal Health's d&a has grown at a 0.2% compound annual growth rate (CAGR), from $783.00M to $790.00M.
- What does d&a mean?
- The accounting process of spreading the cost of physical and intangible assets over time.